Journal Article Epublish 35 citations
PubMed: 34163530 DOI: 10.3389/fgene.2021.678994
Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation.
Front Genet 12:678994
Authors: Chiara Siniscalchi, Armando Di Palo, Aniello Russo, Nicoletta Potenza
Affiliations
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", Caserta, Italy.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel RNA virus affecting humans, causing a form of acute pulmonary respiratory disorder named COVID-19, declared a pandemic by the World Health Organization. MicroRNAs (miRNA) play an emerging and important role in the interplay between viruses and host cells. Although the impact of host miRNAs on SARS-CoV-2 infection has been predicted, experimental data are still missing. This study started by a bioinformatics prediction of cellular miRNAs potentially targeting viral RNAs; then, a number of criteria also based on experimental evidence and virus biology were applied, giving rise to eight promising binding miRNAs. Their interaction with viral sequences was experimentally validated by transfecting luciferase-based reporter plasmids carrying viral target sequences or their inverted sequences into the lung A549 cell line. Transfection of the reporter plasmids resulted in a reduction of luciferase activity for five out of the eight potential binding sites, suggesting responsiveness to endogenously expressed miRNAs. Co-transfection of the reporter plasmids along with miRNA mimics led to a further and strong reduction of luciferase activity, validating the interaction between miR-219a-2-3p, miR-30c-5p, miR-378d, miR-29a-3p, miR-15b-5p, and viral sequences. miR-15b was also able to repress plasmid-driven Spike expression. Intriguingly, the viral target sequences are fully conserved in more recent variants such as United Kingdom variant B.1.1.7 and South Africa 501Y.V2. Overall, this study provides a first experimental evidence of the interaction between specific cellular miRNAs and SARS-CoV-2 sequences, thus contributing to understanding the molecular mechanisms underlying virus infection and pathogenesis to envisage innovative therapeutic interventions and diagnostic tools.
MeSH
Plasmids, Infections, Rna, Luciferases, Viruses, Sars Virus, Micrornas, A549 Cells, Covid-19, Sars-Cov-2
Cited by
- Effect of SARS-CoV-2 infection on host competing endogenous RNA and miRNA network. PeerJ, 2021
- SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs. Virol J, 2023
- Experimental and computational methods for studying the dynamics of RNA-RNA interactions in SARS-COV2 genomes. Brief Funct Genomics, 2024
- The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res, 2022
- MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review. J Infect Public Health, 2022
- Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients. Sci Rep, 2023
- MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. Life Sci, 2022
- MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells, 2022
- Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects. Viruses, 2022
- Contrasting Distribution of SARS-CoV-2 Lineages across Multiple Rounds of Pandemic Waves in West Bengal, the Gateway of East and North-East States of India. Microbiol Spectr, 2022
- The Journal Club: Highlights on Recent Papers-9. Noncoding RNA, 2021
- miRNA expression in COVID-19. Gene Rep, 2022
- SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad. Int J Mol Sci, 2021
- miRNAs: The Key Regulator of COVID-19 Disease. Int J Cell Biol, 2022
- Translation Inhibition Mediated by Interferon-Stimulated Genes during Viral Infections. Viruses, 2024
- Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype. iScience, 2022
- microRNA, the Innate-Immune System and SARS-CoV-2. Front Cell Infect Microbiol, 2022
- Altered microRNA expression in severe COVID-19: Potential prognostic and pathophysiological role. Clin Transl Med, 2022
- Unwanted Exacerbation of the Immune Response in Neurodegenerative Disease: A Time to Review the Impact. Front Cell Neurosci, 2021
- SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease. Front Cell Neurosci, 2022